NCT00194792: Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer |
|
|
| Terminated | 2 | 28 | US | exemestane, Aromasin, FCE-24304, PNU 155971, triptorelin pamoate, Pamorelin, Trelstar Depot, capecitabine, CAPE, Ro 09-1978/000, Xeloda, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, vinorelbine tartrate, Eunades, navelbine ditartrate, NVB, VNB, paclitaxel, Anzatax, Asotax, TAX, Taxol, therapeutic conventional surgery, radiation therapy, irradiation, radiotherapy, therapy, radiation, laboratory biomarker analysis | University of Washington, National Cancer Institute (NCI) | Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer | 07/11 | 07/11 | | |
